Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
Qiqi Liu,1,* Pingping Hu,1,* Guodong Deng,1 Jingxin Zhang,2 Ning Liang,1 Jian Xie,1 Lili Qiao,3 Hui Luo,4 Jiandong Zhang1 1Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Shandong University, Jinan, 2Division of Oncology, Department of Graduate, Weifang Medi...
Main Authors: | Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/soluble-cytotoxic-t-lymphocyte-antigen-4-a-favorable-predictor-in-mali-peer-reviewed-article-OTT |
Similar Items
-
Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
by: Jiajia Liu, et al.
Published: (2021-05-01) -
Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells
by: Qiuqiang Chen, et al.
Published: (2020-09-01) -
Cancer/testis antigens (CTAs) expression in resected lung cancer
by: Jin S, et al.
Published: (2018-08-01) -
In vitro Generation of Cytotoxic T Cells With Potential for Adoptive Tumor Immunotherapy of Multiple Myeloma
by: Wafaa S. Khalaf, et al.
Published: (2019-08-01) -
Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes
by: Ippei Date, et al.
Published: (2021-12-01)